Skip Navigation


JAC Advance Access originally published online on November 28, 2002
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
51/1/183    most recent
dkg021v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Laverdiere, M.
Right arrow Articles by Habel, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laverdiere, M.
Right arrow Articles by Habel, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2003) 51, 183-184
© 2003 The British Society for Antimicrobial Chemotherapy

Correspondence

Adding 2% glucose to culture media does not influence the activity of caspofungin against Candida species

M. Laverdiere*, C. Restieri and F. Habel

Department of Microbiology and Infectious Diseases, Hôpital Maisonneuve-Rosemont, 5415 Boulevard L’Assomption, Montréal, Québec, Canada H1T 2M4

The first 10% of the full text of this article appears below.

Sir,

The activity of antifungal agents in vitro may vary according to procedural variations such as culture media, addition of supplements, incubation duration and endpoint determinations. The appropriate methods to assess the activity in vitro of the new candin antifungals have not been clearly defined. We assessed the influence of the addition of supplemental 2% glucose (2%G) to the culture medium on the activity of caspofungin in vitro against clinically significant Candida isolates.

A total of 50 isolates . . . [Full Text of this Article]

Acknowledgements


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
E. Canton, J. Peman, M. Gobernado, E. Alvarez, F. Baquero, R. Cisterna, J. Gil, E. Martin-Mazuelos, C. Rubio, A. Sanchez-Sousa, et al.
Sensititre YeastOne Caspofungin Susceptibility Testing of Candida Clinical Isolates: Correlation with Results of NCCLS M27-A2 Multicenter Study
Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1604 - 1607.
[Abstract] [Full Text] [PDF]